HECHT BETH (See Remarks) sold 2.9% of their position (40K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $217.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/21/2025ACC: 0001867096-25-000047
Officer· See Remarks
Since Oct 2021
-40K
Net shares
Net seller
$217.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
40K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−40K
Price / share
$5.43
Trade value
$217.24K
% of position
2.9%
3/20/2025
1.39M→1.35M
Total
Net shares
−40K
Net value
-$217.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/20/2025 | S · Sale | −40K | $5.43 | $217.24K | 2.9% | 1.39M | 1.35M |
| Total | −40K | -$217.24K | ||||||
Derivative Transactions0
No derivative transactions reported